Valuation: Bayer AG

Capitalization 36.77B 43.28B 33.67B 31.79B 59.03B 4,079B 59.72B 399B 155B 1,958B 162B 159B 6,771B P/E ratio 2026 *
18.8x
P/E ratio 2027 * 12.4x
Enterprise value 69.01B 81.23B 63.19B 59.67B 111B 7,656B 112B 749B 292B 3,675B 305B 298B 12,708B EV / Sales 2026 *
1.52x
EV / Sales 2027 * 1.42x
Free-Float
100%
Yield 2026 *
0.57%
Yield 2027 * 1.88%
1 day-0.49%
1 week-0.37%
Current month-2.08%
1 month-7.95%
3 months-19.49%
6 months+40.60%
Current year+0.68%
1 week 36.96
Extreme 36.96
38.87
1 month 35.89
Extreme 35.89
41.77
Current year 35.2
Extreme 35.2
49.78
1 year 22.02
Extreme 22.02
49.78
3 years 18.38
Extreme 18.378
58.64
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2018
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 69 01/04/2002
Director/Board Member 55 01/04/2012
Director/Board Member 66 01/04/2022
Change 5d. change 1-year change 3-years change Capi.($)
-0.52%-0.37%+59.09%-36.10% 43.28B
-1.67%-0.81%+27.16%+120.81% 869B
-0.20%-2.25%+42.67%+36.82% 536B
-0.67%-2.79%+8.22%+36.20% 359B
-0.16%-0.60%+18.90%+11.56% 327B
+0.59%-1.15%+31.79%+12.10% 281B
+0.23%-0.47%+24.36%+20.90% 278B
+0.12%-0.26%+44.07%-5.50% 277B
-1.68%+3.99%-32.60%-49.55% 206B
+0.71%+0.43%+21.76%+41.18% 178B
Average -0.31%-0.49%+24.54%+18.84% 335.37B
Weighted average by Cap. -0.54%+0.22%+24.81%+43.16%

Financials

2026 *2027 *
Net sales 45.35B 53.37B 41.52B 39.21B 72.79B 5,030B 73.64B 492B 192B 2,415B 200B 196B 8,350B 46.61B 54.86B 42.68B 40.3B 74.82B 5,170B 75.69B 506B 197B 2,482B 206B 202B 8,583B
Net income 1.92B 2.25B 1.75B 1.66B 3.07B 212B 3.11B 20.79B 8.1B 102B 8.46B 8.28B 353B 2.97B 3.5B 2.72B 2.57B 4.77B 330B 4.83B 32.27B 12.57B 158B 13.13B 12.85B 547B
Net Debt 32.24B 37.94B 29.52B 27.87B 51.75B 3,576B 52.35B 350B 136B 1,717B 142B 139B 5,936B 29.3B 34.48B 26.82B 25.33B 47.03B 3,250B 47.57B 318B 124B 1,560B 129B 127B 5,395B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,280
Date Price Change Volume
08/05/26 37.22 -0.56% 658,952
07/05/26 37.43 -2.80% 2,470,987
06/05/26 38.51 +1.61% 2,624,561
05/05/26 37.90 +1.34% 1,729,639
04/05/26 37.40 -1.71% 1,936,154
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
37.43EUR
Average target price
48.47EUR
Spread / Average Target
+29.50%

Quarterly revenue - Rate of surprise